Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bohuslav Melichar, M.D.
Onkologicka klinika, Fakultni nemocnice Olomouc (OUH)
Principal Investigator - Craig Gordon, D.O.
Michigan Center of Medical Research(MCMR)
Principal Investigator - David Weng, M.D.
Anne Arundel Health System Research Institute (AAHS)
Principal Investigator - Ghassan Aljazayrly, M.D.
California Research Institute (CRI)
Principal Investigator - Jane Skelton, M.D.
Boca Raton Regional Hospital (BRRH)
Principal Investigator - John Ellerton, M.D.
Nevada Cancer Research Foundation (NCRF)
Principal Investigator - Martin Smakal, M.D.
Onkologicky stacionar, NH Hospital a.s., nemocnice Horovice (NHH)
Principal Investigator - Martina Zimovjanova, M.D.
Onkologicka klinika, Vseobecna fakultni nemocnice v Praze (VFN)
Principal Investigator - Neelima Vidula, M.D.
Massachusetts General Hospital (MGH)
Principal Investigator - Priyanka Sharma, M.D.
University of Kansas Medical Center(KUMC)
Principal Investigator - Richard Caradonna, M.D.
ASCLEPES Research Center(ARC)
Principal Investigator - Timothy Pluard, M.D.
Saint Luke's Cancer Institute(SLCI)
Principal Investigator - Yan Ji, M.D.
Metro-Minnesota Community Oncology Research Consortium (MMCORC)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Onkologicka Klinika, Fakultni Nemocnice Olomouc (ouh)
Olomouc, I.P. Pavlova 6, Czechia
- Onkologicky Stacionar, Nh Hospital A.S., Nemocnice Horovice (nhh)
Hořovice, K Nemocnici, Czechia
- Onkologicka Klinika, Vseobecna Fakultni Nemocnice V Praze (vfn)
Prague, U Nemocnice 499/2, Czechia
- California Research Institute (cri)
Los Angeles, California, United States
- University of California San Francisco (ucsf)
San Francisco, California, United States
- Boca Raton Regional Hospital (brrh)
Boca Raton, Florida, United States
- Asclepes Research Center(arc)
Weeki Wachee, Florida, United States
- Saint Luke'S Cancer Institute(slci)
Kansas City, Kansas, United States
- University of Kansas Medical Center(kumc)
Kansas City, Kansas, United States
- Anne Arundel Health System Research Institute (aahs)
Annapolis, Maryland, United States
- Massachusetts General Hospital(mgh)
Boston, Massachusetts, United States
- Michigan Center of Medical Research(mcmr)
Farmington Hills, Michigan, United States
- Metro-Minnesota Community Oncology Research Consortium (mmcorc)
Minneapolis, Minnesota, United States
- Nevada Cancer Research Foundation (ncrf)
Las Vegas, Nevada, United States
- University of Pittsburgh Medical Center (upmc)
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Jul 2018
- Primary completion
- 13 Dec 2022
- Completion
- 13 Dec 2022
- Last update posted
- 16 Feb 2024
- Registered enrollment
- 72
- Registry id
- NCT03326102
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.